TransCanada (TRP) Falls Further As It's Water-Logged And Getting Wetter

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Trade-Ideas LLC identified TransCanada ( TRP) as a "water-logged and getting wetter" (weak stocks crossing below support with today's range greater than 200%) candidate. In addition to specific proprietary factors, Trade-Ideas identified TransCanada as such a stock due to the following factors:

  • TRP has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $36.7 million.
  • TRP has traded 621,900 shares today.
  • TRP traded in a range 215.4% of the normal price range with a price range of $1.73.
  • TRP traded below its daily resistance level (quality: 21 days, meaning that the stock is crossing a resistance level set by the last 21 calendar days. The resistance price is defined by the Price - $0.01 at the time of the signal).

Stocks matching the 'Water-Logged and Getting Wetter' criteria are worthwhile stocks to watch for a variety of factors including historical back testing and volatility. Trade-Ideas targets these opportunities because the stock is exhibiting an unusual behavior while displaying negative price action. In this case, the stock crossed an important inflection point; namely, "support" while at the same time the range of the stock's movement in price is twice its normal size. This large range foreshadows a possible continuation as the stock moves lower.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in TRP with the Ticky from Trade-Ideas. See the FREE profile for TRP NOW at Trade-Ideas

If you liked this article you might like

Keystone Pipeline Critics Appealing to GOP's Favorite Issues in Nebraska Battle

TransCanada to Decide on Keystone XL Pipeline Investment by December

Nobody's Interested: TransCanada Facing New Keystone XL Issue

Energy Transfer's Pipeline Spill Problem Is Causing It Another Headache

Week in Review: Stocks See Worst Week Since Election as Trump Dealt Setback With Health-Care Bill